Monocyte-mediated-antibody-dependent cellular cytotoxicity (MO-ADCC) was studied in 21 patients with Hodgkin's disease (HD), 15 patients with a long-lasting remission of HD, 11 patients with non-Hodgkin's lymphoma (NHL), 11 patients with solid tumors, and 15 normal controls. Lymphocyte ADCC (LY-ADCC
Antibody dependent cell mediated cytotoxicity (ADCC) in malignant and benign skin disease
✍ Scribed by Sucha O. Asbell; Nancy Gadol; Paul Saluk; Eric Vonderheid; Luther W. Brady
- Publisher
- Elsevier Science
- Year
- 1977
- Tongue
- English
- Weight
- 87 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Antibody-dependent cell-mediated cytotoxicity (ADCC) exhibited by peripheral blood leukocytes was used as a criterion for assessing immune competence of groups of noncancerous individuals and of treated and untreated cancer patients. The results show that, as a group, leukocytes of nontreated cancer
## Abstract The antibody reactive in antibody‐dependent, cell‐mediated cytotoxicity (ADCC) to influenza virus‐infected cells was measured in two groups of seven volunteers each, before and after immunization with inactivated or live attenuated A/Victoria/3/75 influenza virus vaccines. Age‐matched c
## Abstract Serial samples of sera from patients with African Burkitt's lymphoma were tested for antibody against Epstein‐Barr virus (EBV)‐specific membrane antigen (MA) by the antibody‐dependent cell‐mediated cytotoxicity assay (ADCC). Titers of patients in the long‐term survivor group were genera